Rabelink TJ - Search Results

1

Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes.

van Etten RW, de Koning EJ, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ. van Etten RW, et al. Among authors: rabelink tj. Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):799-804. doi: 10.1161/01.atv.0000015330.64968.c4. Arterioscler Thromb Vasc Biol. 2002. PMID: 12006393

2

Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis.

Beutler JJ, Koomans HA, Rabelink TJ, Gaillard CA, Van Hattum J, Boer P, Dorhout Mees EJ. Beutler JJ, et al. Among authors: rabelink tj. Hepatology. 1989 Aug;10(2):148-53. doi: 10.1002/hep.1840100205. Hepatology. 1989. PMID: 2526072

3

Role of ANP in natriuresis of head-out immersion in humans.

Rabelink TJ, Koomans HA, Boer P, Gaillard CA, Dorhout Mees EJ. Rabelink TJ, et al. Am J Physiol. 1989 Sep;257(3 Pt 2):F375-82. doi: 10.1152/ajprenal.1989.257.3.F375. Am J Physiol. 1989. PMID: 2528914

4

Opposite effects of enalapril and nitrendipine on natriuretic response to atrial natriuretic factor. Renal function evaluated with clearance studies in humans.

Gaillard CA, Koomans HA, Rabelink TJ, Boer P, Dorhout Mees EJ. Gaillard CA, et al. Among authors: rabelink tj. Hypertension. 1989 Feb;13(2):173-80. doi: 10.1161/01.hyp.13.2.173. Hypertension. 1989. PMID: 2536642

5

Enhanced natriuretic effect of atrial natriuretic factor during mineralocorticoid escape in humans.

Gaillard CA, Koomans HA, Rabelink TJ, Braam B, Boer P, Dorhout Mees EJ. Gaillard CA, et al. Among authors: rabelink tj. Hypertension. 1988 Oct;12(4):450-6. doi: 10.1161/01.hyp.12.4.450. Hypertension. 1988. PMID: 2971618

6

Impaired endothelial function in patients with nephrotic range proteinuria.

Stroes ES, Joles JA, Chang PC, Koomans HA, Rabelink TJ. Stroes ES, et al. Among authors: rabelink tj. Kidney Int. 1995 Aug;48(2):544-50. doi: 10.1038/ki.1995.325. Kidney Int. 1995. PMID: 7564124 Free article.

7

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Stroes ES, et al. Among authors: rabelink tj. Lancet. 1995 Aug 19;346(8973):467-71. doi: 10.1016/s0140-6736(95)91322-x. Lancet. 1995. PMID: 7637480

8

Mechanisms of cardiovascular injury in renal disease.

Rabelink TJ, Stroes ES, Koomans HA. Rabelink TJ, et al. Blood Purif. 1996;14(1):67-74. doi: 10.1159/000170245. Blood Purif. 1996. PMID: 8718568 Review.

9

Endothelin in renal pathophysiology: from experimental to therapeutic application.

Rabelink TJ, Kaasjager KA, Stroes ES, Koomans HA. Rabelink TJ, et al. Kidney Int. 1996 Dec;50(6):1827-33. doi: 10.1038/ki.1996.502. Kidney Int. 1996. PMID: 8943463 Free article. Review. No abstract available.

10

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Lüscher T, Rabelink T. Stroes E, et al. J Clin Invest. 1997 Jan 1;99(1):41-6. doi: 10.1172/JCI119131. J Clin Invest. 1997. PMID: 9011574 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters